Menu
Urology & Andrology

Leydig Cell Tumor

ICD-10 Code
C62.90_2

Clinical Criteria for Leydig Cell Tumor.

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient presents with a palpable, firm, non-tender testicular mass. History significant for potential endocrine manifestations, including gynecomastia, decreased libido, or erectile dysfunction due to hormonal secretion (estrogen/testosterone). No history of trauma or acute inflammatory symptoms.

Clinical Examination Findings

Physical examination reveals a solid, unilateral testicular nodule. Scrotal ultrasound demonstrates a hypoechoic, hypervascularized intratesticular lesion. Systemic exam notes absence of lymphadenopathy; check for secondary sexual characteristics, specifically gynecomastia, indicating hormonal activity.

Treatment Protocol

Recommended management is radical inguinal orchiectomy. Post-operative surveillance protocol includes serial serum tumor markers (AFP, beta-hCG, LDH) and testosterone/estradiol levels. Imaging follow-up with abdominal/pelvic CT scan to monitor for retroperitoneal lymphadenopathy.

Detailed clinical guide coming soon.